Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied DNA Sciences Inc APDN

Technology Scientific & Technical Instruments
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Stony Brook University Hospital Launches COVID-19 Surveillance Testing Program Powered by Applied DNA's Assay Kit and Services

Business Wire November 10, 2020

Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications

Business Wire November 2, 2020

Applied DNA to Increase COVID-19 Surveillance Testing Utility for its Linea(TM) COVID-19 Assay Kits Through Expanded Use of Robotic Automation

Business Wire October 30, 2020

Applied DNA Secures $1.0+ Million in COVID-19 Surveillance Testing Annualized Revenue, Builds Sales Pipeline for Test Kit and Testing-as-a-Service

Business Wire October 12, 2020

Applied DNA Announces Repayment of Secured Convertible Notes

Business Wire October 8, 2020

Applied DNA Signs Master Services Agreement with Stony Brook University Hospital for COVID-19 Diagnostic Assay Kit and Automated Systems, Receives Initial Purchase Order

Business Wire September 29, 2020

Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment

Business Wire September 21, 2020

Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate

Business Wire September 16, 2020

Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15

Business Wire September 2, 2020

Applied DNA Provides Update on Status of New York State Laboratory Permit for Clinical Labs Subsidiary

Business Wire August 27, 2020

Applied DNA Positions LinearDNA(TM) Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing

Business Wire August 17, 2020

Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging

Business Wire August 12, 2020

Applied DNA Reports Fiscal Third Quarter 2020 Financial Results

Business Wire August 6, 2020

FDA Approves EUA Amendment Increasing Applied DNA's COVID-19 Diagnostic Kit Testing Capacity Through Use of Automated RNA Extraction and Expands Supported Platforms

Business Wire July 31, 2020

Applied DNA to Report Fiscal 2020 Third Quarter Financial Results After Market Close on August 6, 2020

Business Wire July 30, 2020

Applied DNA and Takis Report Positive Preclinical Results from LineaDNA(TM) Vaccine Candidates for COVID-19

Business Wire July 17, 2020

Applied DNA Appoints New Head of Investor Relations and Corporate Communications

Business Wire July 15, 2020

Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea(TM) COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment

Business Wire July 9, 2020

Applied DNA Sciences Set to Join Russell Microcap Index

Business Wire June 26, 2020

Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates

Business Wire June 9, 2020